Keck School Faculty

Naomi Rachel Schechter, MD
Naomi Rachel Schechter, MD
Associate Professor of Clinical Radiation Oncology;Director of Quality & Safety - Keck Medical Center
Radiation Oncology
GNH 1100 N. State Street Health Sciences Campus Los Angeles
Dr. Naomi Rachel Schechter is an Associate Professor of Clinical and Director of Quality and Safety at the Department of Radiation Oncology at Keck Medical Center of USC, specializing in the treatment of head and neck and breast cancers.  As the Director of Quality and Safety for Radiation Oncology, she plays a central role in building uniformity in policies and procedures, adopting national best practices and enforcing quality control and quality improvement in radiation oncology across the USC Health system.

Prior to coming to USC, she was on faculty at the University of California, San Francisco for 7 years where she served as Vice Chair and Director of Quality Assurance and Patient Safety in the UCSF Department of Radiation Oncology. She was previously on faculty at the University of Texas, MD Anderson Cancer Center, in Houston, TX for 6 years.  She also served as a radiation oncologist at The Permanente Medical Group (TPMG) at Kaiser Oakland Medical Center for 2 years treating a wide variety of cancers including using high dose rate brachytherapy for endometrial cancers.

She has received numerous awards, including being elected to Best Doctors in America.

Clinical Expertise: Head and Neck and Breast Cancer

Factors Leading to Decreased Rates of Immediate Postmastectomy Reconstruction J Surg Res. 2019 Feb 14; 238:207-217. . View in PubMed

Radiotherapy quality assurance and patient safety director presents: Accreditation survey day: Story experience & tips Pract Radiat Oncol. 2018 May - Jun; 8(3):141-144. . View in PubMed

Radiation Oncology Practice Accreditation: A Story of the Surveyor Experience J Am Coll Radiol. 2018 May; 15(5):787-788. . View in PubMed

Development of a Radiation Oncology Resident Continuity Clinic to Improve Clinical Competency and Patient Compliance Int J Radiat Oncol Biol Phys. 2018 Mar 01; 100(3):551-555. . View in PubMed

Challenges in using liquid biopsies for gene expression profiling Oncotarget. 2018 Jan 23; 9(6):7036-7053. . View in PubMed

Radiation Oncology Practice Accreditation: A Story of the Surveyor Experience J Am Coll Radiol. 2018 05; 15(5):787-788. . View in PubMed

Development of a Radiation Oncology Resident Continuity Clinic to Improve Clinical Competency and Patient Compliance Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):551-555. . View in PubMed

Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status Breast J. 2014 Jul-Aug; 20(4):358-63. . View in PubMed

Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):91-9. . View in PubMed

Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancer Eur J Nucl Med Mol Imaging. 2009 Oct; 36(10):1583-91. . View in PubMed

Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy Radiother Oncol. 2009 Feb; 90(2):213-20. . View in PubMed

Technologies for translational imaging using generators in oncology Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):251-8. . View in PubMed

Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):152-9. . View in PubMed

The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy Int J Radiat Oncol Biol Phys. 2006 Sep 01; 66(1):76-82. . View in PubMed

The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"? Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65(5):1345-52.. View in PubMed

Immediate breast reconstruction can impact postmastectomy irradiation Am J Clin Oncol. 2005 Oct; 28(5):485-94. . View in PubMed

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy Int J Radiat Oncol Biol Phys. 2005 Jun 01; 62(2):351-7. . View in PubMed

Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol. 2004 Dec 01; 22(23):4691-9. . View in PubMed

Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients J Natl Cancer Inst. 2004 Nov 17; 96(22):1676-81. . View in PubMed

Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neck J Nucl Med. 2004 Oct; 45(10):1683-7. . View in PubMed

Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1337-42. . View in PubMed

Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1074-9. . View in PubMed

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience J Clin Oncol. 2004 Jun 15; 22(12):2303-12. . View in PubMed

T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):138-45. . View in PubMed

Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer. 2004 Mar 15; 100(6):1171-8.. View in PubMed

The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):876-87. . View in PubMed

Advances in radiation treatments of breast cancer Clin Breast Cancer. 2004 Feb; 4(6):401-6. . View in PubMed

Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival J Clin Oncol. 2003 Sep 01; 21(17):3244-8. . View in PubMed

Uncertainties in physical and biological targeting with radiation therapy Rays. 2003 Jul-Sep; 28(3):211-5. . View in PubMed

Basal cell nevus syndrome concurrent with adenoid cystic carcinoma of salivary gland J Am Acad Dermatol. 2003 May; 48(5 Suppl):S64-6. . View in PubMed

Adjuvant irradiation for cervical lymph node metastases from melanoma Cancer. 2003 Apr 01; 97(7):1789-96. . View in PubMed

Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003 Feb 01; 55(2):322-8.. View in PubMed

Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents Radiology. 2003 Feb; 226(2):465-73. . View in PubMed

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody Anticancer Drugs. 2003 Jan; 14(1):49-56. . View in PubMed

Assessment of antiangiogenic effect using 99mTc-EC-endostatin Cancer Biother Radiopharm. 2002 Apr; 17(2):233-45. . View in PubMed

Powered by SC CTSI
Go to Top